levofloxacin has been researched along with tetracaine in 5 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (tetracaine) | Trials (tetracaine) | Recent Studies (post-2010) (tetracaine) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 2,688 | 349 | 274 |
| Protein | Taxonomy | levofloxacin (IC50) | tetracaine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 3.268 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.317 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.415 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 3.268 | |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 0.056 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.5075 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 1.4693 | |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 0.795 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.673 | |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 0.74 | |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 0.52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
5 other study(ies) available for levofloxacin and tetracaine
| Article | Year |
|---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |